Table of Contents
Table 5-73: Shelby
Table 5-75: Starke
| Primary Site | Incidence | Mortality | ||||||
|---|---|---|---|---|---|---|---|---|
| 2002 | 1998 - 2002 | 2002 | 1998 - 2002 | |||||
| Count | Rate | Count | Rate | Count | Rate | Count | Rate | |
| All Sites | 56 | 564.9 | 264 | 544.6 | 28 | 299.1 | 121 | 267.7 |
| Esophagus | * | # | 4 | # | * | # | 4 | # |
| Stomach | * | # | 6 | 12.0** | * | # | 2 | # |
| Colon excluding Rectum | * | # | 34 | 72.3 | * | # | 6 | 12.5** |
| Rectum and Rectosigmoid Junction | * | # | 10 | 18.6** | * | # | 0 | # |
| Liver | * | # | 3 | # | * | # | 3 | # |
| Pancreas | * | # | 5 | 9.9** | * | # | 4 | # |
| Lung and Bronchus | 11 | 108.1** | 46 | 94.5 | 18 | 183.2** | 44 | 92.6 |
| Melanoma of the Skin | * | # | 5 | 9.4** | * | # | 3 | # |
| Prostate | 12 | 112.3** | 61 | 125.9 | * | # | 9 | 25.0** |
| Urinary Bladder | * | # | 20 | 44.9 | * | # | 6 | 16.8** |
| Kidney and Renal Pelvis | * | # | 11 | 22.9** | * | # | 2 | # |
| Brain and Other Nervous System | * | # | 4 | # | * | # | 3 | # |
| Non-Hodgkin Lymphoma | * | # | 9 | 16.8** | * | # | 6 | 13.2** |
| Myeloma | * | # | 1 | # | * | # | 2 | # |
| Leukemia | * | # | 9 | 19.3** | * | # | 7 | 15.4** |
| Primary Site | Incidence | Mortality | ||||||
|---|---|---|---|---|---|---|---|---|
| 2002 | 1998 - 2002 | 2002 | 1998 - 2002 | |||||
| Count | Rate | Count | Rate | Count | Rate | Count | Rate | |
| All Sites | 44 | 383.3 | 211 | 372.0 | 21 | 179.1 | 81 | 139.3 |
| Colon excluding Rectum | * | # | 22 | 37.5 | * | # | 11 | 18.8** |
| Rectum and Rectosigmoid Junction | * | # | 2 | # | * | # | 0 | # |
| Liver | * | # | 0 | # | * | # | 0 | # |
| Pancreas | * | # | 6 | 10.2** | * | # | 4 | # |
| Lung and Bronchus | * | # | 26 | 45.9 | * | # | 19 | 32.9** |
| Melanoma of the Skin | * | # | 2 | # | * | # | 0 | # |
| Breast | 13 | 110.7** | 73 | 128.0 | * | # | 8 | 13.8** |
| Cervix Uteri | * | # | 4 | # | * | # | 3 | # |
| Corpus Uteri | * | # | 11 | 19.3** | * | # | 0 | # |
| Ovary | * | # | 6 | 10.5** | * | # | 2 | # |
| Urinary Bladder | * | # | 4 | # | * | # | 0 | # |
| Kidney and Renal Pelvis | * | # | 3 | # | * | # | 1 | # |
| Brain and Other Nervous System | * | # | 1 | # | * | # | 1 | # |
| Non-Hodgkin Lymphoma | * | # | 12 | 21.7** | * | # | 9 | 16.1** |
| Myeloma | * | # | 2 | # | * | # | 0 | # |
| Leukemia | * | # | 7 | 12.0** | * | # | 6 | 10.0** |
Rates are per 100,000; Age-adjusted, 2000 US Std Million Million.
* Fewer than 5 cases, number suppressed to protect confidentiality.
** Rates based on fewer than 20 cases are unstable.
# Rate cannot be calculated.
Source: Indiana State Department of Health - Indiana State Cancer Registry and the Epidemiology Resource Center, Data Analysis Team, July 2005
Table of Contents
Table 5-73: Shelby
Table 5-75: Starke
